Sansure new generation “ Advanced Magnetic Beads Technology” using exclusive modified super-paramagnetic nano-beads to absorb sample DNA/RNA , only needs a simple step of washing to obtain high purity nucleic acid, combined with the "DNA/RNA elution-free " technology and integrate efficient amplification system, to achieve DNA/RNA amplification detection with magnatic beads. It can realize high sensitivity and wide linear range PCR detection with good reproducibility , strong anti-interference ability and multiple genotypes coverage.

Based on Sansure “Advanced Magnetic Beads Technology”, we upgrade to modified superparamagnetic nano-bead technology , which can be applied in DNA/RNA extraction of common sample types such as serum, plasma, secretions, exfoliated cells, throat swabs, anal swabs, urine, feces, sputum, whole blood, tissues, paraffin sections. We combine the modified superparamagnetic nano-bead technology with fully automated nucleic acid extraction instrument to achieve unified sample DNA/RNA extracion, namely "unified release reagent + unified process" extraction. This method fixes the bottleneck that the traditional method needs to process DNA/RNA samples separately for different items, different sample types and different time periods, and improves the efficiency of clinical detection .

Based on the conventional fluorescence PCR instrument, Sansure has independently developed and upgraded "Multiplex fluorescent PCR-amplification technology" from the aspects of amplification reaction buffer system and probe labeling technology, etc., This technology creatively combined with the detection technology of TaqMan probe and melting curve. It also overcomes the limitation of single channel detection of one target, realize the detection and analysis of at least two targeted targets in the monochromatic fluorescent channel simultaneously, detect at least eight targets in one reaction tube at the same time, and realize the rapid and accurate identification and diagnosis of multiple pathogens.

Sansure integrates "one-tube fast release technology" , "rapid PCR amplification technology" and further optimizes sample processing, nucleic acid extraction and purification, PCR amplification, fluorescence detection and result processing modules to advanced portable mobile molecular detection workstation.This system greatly reduces the detection time to only 8-45 minutes, and at the same time has high-level mobility and adaptability, It breaks through the limits of the experimental site and complex instruments and has a wide range of application scenarios.

Sansure Immunological Technology Platform adopts advanced nanoparticle technology, protein labelling and modification technology, using high quality coloured latex and colloidal gold as tracers, and has developed a series of easy-to-use, highly sensitive and rapid detection products, covering SARS-CoV-2 antigen, SARS-CoV-2/InFluA/InFluB antigen, SARS-CoV-2 neutralizing antibody and other SARS-CoV-2 immunological reagents, to meet the needs of different scenarios such as home self-test, POCT and laboratory testing.

High-throughput sequencing enables wider application with higher throughput and better precision. Our system is compatible with most popular NGS libraries available in the market, ensuring flexibility and broad applicability. To illustrate its capabilities, let's consider mNGS (metagenomic Next-Generation Sequencing) as an example. Using our platform with SE75 read length, the sequencing cycle can be completed in just 13 hours.

The Bioinformatics platform represents another leap forward in diagnostic capabilities. By creating a comprehensive life and health database, we've enabled one-click analysis and automatic report generation, eliminating the need for manual interpretation. Significantly enhanced the efficiency and accuracy of diagnosis.

Our eECL (enhanced Electrochemiluminescence) technology offers stronger signals with lower noise levels and higher sensitivity compared to traditional methods. The incubation time is remarkably short at just 5 minutes, with the first report available within 8 minutes, which is very crucial for emergency diagnostics. Currently, we're focusing on offering tests for inflammatory markers and myocardial markers, such as troponin and myosin.